Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium vs Atrovent in COPD
NCT00239434Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Trough Forced Expiratory Volume in one second response at 4 weeks. Started Jun 2003; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00239434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239434.